Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...

SEQSTER PDM, Inc. ("SEQSTER"), the leading healthcare technology company powering the connection, collection, and orchestration layer of patient health data, today launched 1-Clic ...

NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced new experiences for enhancing and ...

An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...

Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...

FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...

In 2014, the European Medicines Agency (EMA) made headlines when it announced it would require pharmaceutical companies to report the results of their clinical trials. Now, in a new notice, EMA is ...

The FDA has sent letters to more than 2,200 sponsors and investigators regarding more than 3,000 studies.

The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters pressing drug manufacturers, ...

Obsidian Therapeutics, Inc., a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...

Incyte (Nasdaq:INCY) today announced that full results from the Phase 3 pivotal study evaluating tafasitamab (Monjuvi ® /Minjuvi ®) in first-line diffuse large b-cell lymphoma (DLBCL) will be featured ...